Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

MLV & Co. Has Positive Takeaways From Carrizo Oil & Gas Management Meeting

Share:

In a report published Friday, MLV & Co. analyst Chad Mabry reiterated a Buy rating and $86.00 price target on Carrizo Oil & Gas (NASDAQ: CRZO).

In the report, MLV & Co noted, “We hosted CRZO management for investor meetings in Portland and Seattle earlier this week. Significant client interest and positive company commentary reinforce our investment thesis on the name. We believe the Street is undervaluing CRZO's core assets and expect ongoing execution to drive the stock toward our $86 price target. We reiterate our Buy rating and top pick status.”

Carrizo Oil & Gas closed on Thursday at $65.23.

Latest Ratings for CRZO

DateFirmActionFromTo
May 2019ReinstatesMarket Perform
Apr 2019DowngradesOutperformMarket Perform
Apr 2019Initiates Coverage OnMarket Perform

View More Analyst Ratings for CRZO
View the Latest Analyst Ratings

Posted-In: Chad Mabry MLV & Co.Analyst Color Reiteration Analyst Ratings

 

Related Articles (CRZO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MCDMaintains200.0
AVGOMaintains300.0
AVGOMaintains315.0
CASYMaintains152.0
MRKMaintains93.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Morning Market Losers

Novartis Joins Google To Develop Contacts For Diabetics